Perianal Extramammary Paget’s Disease: More Than Meets the Eye
Case Presentation and Evolution
A 75-year-old man was initially evaluated for a 1-year history of perianal pruritus that was refractory to multiple topical therapies. He had a sharply demarcated, erythematous and scaly rash involving the left perianal skin, originating from the left hemi-circumference of the anal verge and extending anteriorly, laterally and posteriorly to involve a 6 cm × 4 cm area of skin (Fig. 1). A punch biopsy of the lesion confirmed extramammary Paget’s disease (EMPD). Immunostaining of the biopsy was positive for cytokeratin (CK)7 and GATA3, weakly positive for cytokeratin 20, and negative for CDX2 and prostate-specific antigen (PSA), all consistent with likely primary EMPD. Patient’s past history was notable for coronary artery disease and prostate cancer, for which he had undergone prostatectomy. His recent serum PSA had been unremarkable at 0.02 ng/mL. PSA immunostaining of the punch biopsy was negative, as was urine cytology, excluding underlying urothelial...
- 26.Vereecken P, Awada A, Ghanem G, Marques da Costa C, et al. A therapeutic approach to perianal extramammary Paget’s disease: topical imiquimod can be useful to prevent or defer surgery. Med Sci Monit. 2007;13:75–77.Google Scholar
- 27.Zampognoa JC, Flowers FP, Roth WI, Hassenein AM. Treatment of primary limited cutaneous extramammary Paget’s disease with topical imiquimod monotherapy: two case reports. J Am Acad Dermatol. 2004;4:229–235.Google Scholar
© Springer Science+Business Media, LLC, part of Springer Nature 2018